Bioactive Evaluation and Cytotoxicity of Quinolones with Metronidazole

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:lonlychanging
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Hybrids of metronidazole and quinolones as antimicrobial agents were developed and their bioactive assay that the newly synthesized compounds exhibited good or even stronger antimicrobial activities against the tested strains including multi-drug resistant MRSA in comparison with reference drugs norfloxacin,chloromycin and fluconazole.Cell toxicity disclosed that highly active target compounds did not show toxicity to A549 cell line within the concentration of 256 μg/mL.
其他文献
Aims: Afatinib is a potent,irreversible and double tyrosine kinases inhibitor of EGFR and HER2,so we target is to synthesis and optimize the synthesis technology of afatinib and make it more suitable
会议
Aims:NVP-BEZ235 is the development of a Novartis ATP competitive inhibition of PI3K/mTOR anticancer drug and inhibition the catalytic activity of Akt and mTOR.This paper introduces the research progre
Vandetanib(1)is a kind of tryrosine kinase inhibitors.It is a potent inhibitor of VEGF RTK and also has some activity against epidermal growth factor(EGF)RTK[1].It inhibits the effects of VEGF and is
c-Met is a proto-oncogene that encode a protien known as hepatocyte growth factor receptor(HGFR)[1].Inappropriate activity of c-Met can cause wide variety of different cancers such as breast,pancreas,
会议
Hemagglutinin(HA)which is essential for influenza viral infection and replication has become a target for the design of anti-influenza drugs.A novel series of oligothiophene compounds focused on the t
Chiral BINOL-based phosphoric acids are an array of privileged and bifunctional organocatalysts,the activities of which have been successfully demonstrated in a variety of organic transformations.[1]
Bacterial resistance continues to progress and pose a significant threat,both in hospitals and,more recently,in the community.
A series of novel 3-aminothiazolquinolones as newly structural antibacterial agents were designed and synthesized for the first time.